NASDAQ | ETF
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 11.56% |
NVO | Novo Nordisk A/S | Healthcare | Biotechnology | 9.7% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.45% |
JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.42% |
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 5.94% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.54% |
NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 4.94% |
MCK | McKesson Corporation | Healthcare | Medical Distribution | 4.8% |
SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 4.78% |
ABC | AmerisourceBergen | Healthcare | Medical Distribution | 4.76% |
H6D | Haleon PLC | null | null | 4.71% |
GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 4.48% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.34% |
TAK | Takeda Pharmaceutical Co Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.12% |
ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.01% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 3.9% |
TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 2.85% |
VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.87% |
JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 1.03% |
CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 0.96% |
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.